Dr. Chad T Pfefer , MD
Internal Medicine • Beaverton, OR
1920 Nw Amberglen Pkwy, Ste 150
Beaverton, OR 970066977
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 31, 2006; this date does not establish years in practice.
-
Published CMS data list 28 Medicare Part D prescriptions, including refills, in 2016.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2016. Published rows only; this is not a quality measure.
-
Published Part D records, 2016:
- Toviaz (Fesoterodine Fumarate) — 16 prescription fills, including refills.
- Humalog Kwikpen U-100 (Insulin Lispro) — 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2016. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 5,487 in 2013 to 28 in 2016.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2013–2016.
Practice Location & Contact Primary Location
1920 Nw Amberglen Pkwy
Ste 150
Beaverton, OR 970066977
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
28 standardized 30-day fills in 2016
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$4,578 in 2016
The total cost of these prescriptions in 2016, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2016.
Open Payments general payments, program year 2025
All general payments: $142,360.00 across 98 records.
By nature of payment
- Consulting Fee: $142,360.00 across 98 records.
Reporting-company totals
- CSL Plasma Inc.: $142,360.00 across 98 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Beaverton and Oregon
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Pfefer are from 2016.
46 active clinicians are listed under Internal Medicine with a practice address in Beaverton, OR (2,118 in Oregon).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Beaverton
30.4% of these 46 clinicians have the CMS telehealth indicator.
71.7% of these 46 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 99% from 5,487 in 2013 to 28 in 2016.
- 2013: 5,487
- 2014: 6,008
- 2015: 3,056
- 2016: 28
-
30-day fills
30-day fills decreased 100% from 7,869 in 2013 to 28 in 2016.
- 2013: 7,869
- 2014: 8,580
- 2015: 4,373
- 2016: 28
-
Part D drug cost
Part D drug cost decreased 98% from $183,199 in 2013 to $4,578 in 2016.
- 2013: $183,199
- 2014: $191,047
- 2015: $88,886
- 2016: $4,578
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 61% from $88,485.11 in 2019 to $142,360.00 in 2025.
- 2019: $88,485.11
- 2020: $114,311.25
- 2021: $130,256.00
- 2022: $163,686.50
- 2025: $142,360.00
Sources: CMS Medicare Part D Prescribers (2016), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 98 records totaling $142,360.00.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,300.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,200.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,000.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,860.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,800.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,600.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,560.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,500.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,450.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,400.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,200.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,060.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,050.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,000.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,000.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,980.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,900.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,900.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,900.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,900.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,660.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,660.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,600.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,580.00 |
| CSL Plasma Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,560.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2016.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Toviaz | Fesoterodine Fumarate | 16 | 224 | $1,984.50 | — |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | 168 | $2,593.12 | — |
Source: CMS Part D by Provider and Drug, 2016; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Career & Practice History
NPI enumerated August 31, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Beaverton
- Dr. Liza Rodriguez Jimenez, MD
- Dr. Richard Bills, MD
- Dr. Erica Veazey, MD
- Merin Jose
- Dr. Edmund Torkelson, DO
- Dr. Madhvi Wanchu, MD
Mailing Address
1920 Nw Amberglen Pkwy, Ste 150
Beaverton, OR 970066977
Phone: 9713274356